Test Kit is for in-vitro diagnostic (IVD) use to determine Glycated Albumin (GA) and Albumin quantitatively from serum or plasma. It is useful at initial assessment, the onset of therapy, and post-therapeutic monitoring of glycemic control.
World's first Glycated albumin test for Point-of-care
Glycated Albumin reflects average blood glucose concentration over the previous 2-4 weeks; used in the management of insulin therapy for diabetes mellitus. Glycated Albumin rapidly confirms treatment efficacy due to shorter half-life than HbA1c.